Research
Read how they describe their research on their University of Alberta profile.
Latest papers
Piecing together human adult comparative pharmacokinetic trials and rodent studies: What happens to drug clearance in obesity?
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2022 · first author
Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis.
The Journal of pharmacology and experimental therapeutics · 2018
Role of Environmental Factors in the Development of Pediatric Eosinophilic Esophagitis.
Digestive diseases and sciences · 2015
Latest funding
- $1,269,900
Peripheral Co-Activation of Orexin and GLP-1 Receptors for Obesity Treatment with Muscle Preservation
CIHR · 2026 · Co-investigator
- $1,032,750
Role of cytochrome P450 enzymes in pathogenesis of cardiac hypertrophy during menopause
CIHR · 2025 · Co-investigator
- $707,625
Clozapine toxicity mechanisms and mitigation strategies
CIHR · 2023 · Co-investigator
3 publications.
Piecing together human adult comparative pharmacokinetic trials and rodent studies: What happens to drug clearance in obesity?
Brocks D, Al Nebaihi H, Parvin S, Hamza A
Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis.
Salla M, Aguayo-Ortiz R, Danmaliki GI, Zare A, Said A, Moore J, Pandya V, Manaloor R, Fong S, Blankstein AR, Gibson SB, Garcia LR, Meier P, Bhullar KS, Hubbard BP, Fiteh Y, Vliagoftis H, Goping IS, Brocks D, Hwang P, Velázquez-Martínez CA, Baksh S
Role of Environmental Factors in the Development of Pediatric Eosinophilic Esophagitis.
Slae M, Persad R, Leung AJ, Gabr R, Brocks D, Huynh HQ
Peripheral Co-Activation of Orexin and GLP-1 Receptors for Obesity Treatment with Muscle Preservation
Principal investigators: Tabatabaei Dakhili, Seyed Amirhossein
Keywords: Drug Discovery; Drug Discovery And Development; Glp1 Receptor Agonist; Obesity; Orexins; Peptide Therapeutics
Role of cytochrome P450 enzymes in pathogenesis of cardiac hypertrophy during menopause
Principal investigators: El-Kadi, Ayman O
Keywords: Arachidonic Acid; Cardiac Hypertrophy; Cardiovascular Pharmacology; Cytochrome P450; Drug Metabolism; Menopause
Clozapine toxicity mechanisms and mitigation strategies
Principal investigators: Siraki, Arno
Keywords: Adverse Drug Reactions; Clozapine; Drug Toxicity; Edaravone; Myeloperoxidase; Neutrophils
Discovery and Development of Brain-Sparing Inhibitors of Succinyl-CoA:3-Ketoacid CoA Transferase
Principal investigators: Ussher, John R
Keywords: Chemical Synthesis; Ketone Body Oxidation; Molecular Modeling; Preclinical Drug Development; Structure-Guided Drug Design; Succinyl Coa:3-Ketoacid Coa Transferase
Targeting Neuroplasticity After Neonatal Brain Injury
Principal investigators: Kalish, Brian
Keywords: brain injury newborn neuroprotection neuroplasticity hypoxic ischemic encephalopathy
Role of cytochrome P450 enzymes in pathogenesis of cardiac hypertrophy in different sexes
Principal investigators: El-Kadi, Ayman O
Keywords: Arachidonic Acid; Cardiac Hypertrophy; Cardiovascular Pharmacology; Cytochrome P450; Drug Metabolism; Gene Expression
Pharmacological Characterization of eNOS-based Platelet Subpopulations
Principal investigators: Jurasz, Paul K
Keywords: Anti-Platelet Drugs; Endothelial Nitric Oxide Synthase; Flow Cytometry; Matrix Metalloproteinases; Myocardial Infarction; Nitric Oxide; Pharmacology; Platelet Function Testing; Platelets; Prognostic Biomarkers
Tumor targeted polymeric nanocarriers for oncogene silencing therapy of metastatic breast cancer
Principal investigators: Lavasanifar, Afsaneh
Keywords: Cancer Chemotherapy; Drug Delivery; Drug Resistance; Nanotechnology; Sirna Delivery; Targeted Therapy
Ligand guided polymeric nano-carriers for tumor targeted drug and oncogene silencing therapy: A strategy for chemosensitization of resistant cancers
Principal investigators: Lavasanifar, Afsaneh
Keywords: Cancer Chemotherapy; Drug Delivery; Drug Resistance; Nanotechnology; Sirna Delivery; Targeted Therapy
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
- Harissios Vliagoftis and Peter Hwang: 1 shared paper
- Harissios Vliagoftis and Ing Goping: 1 shared paper
- Harissios Vliagoftis and Basil Hubbard: 1 shared paper
- Harissios Vliagoftis and Dion Brocks: 1 shared paper
- Peter Hwang and Ing Goping: 1 shared paper
- Peter Hwang and Basil Hubbard: 1 shared paper
- Peter Hwang and Dion Brocks: 1 shared paper
- Ing Goping and Basil Hubbard: 1 shared paper
- Ing Goping and Dion Brocks: 1 shared paper
- Basil Hubbard and Dion Brocks: 1 shared paper
- Rabin Persad and Dion Brocks: 1 shared paper
- Medicine Dept
- Biochemistry Dept
- Pediatrics Dept
- Other
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Spencer Gibson
Manitoba Institute of Cell Biology
1 shared papers, latest 2018
Harissios Vliagoftis
Medicine Dept
1 shared papers, latest 2018
Peter Hwang
Medicine Dept
1 shared papers, latest 2018
Ing Goping
Biochemistry Dept
1 shared papers, latest 2018
Basil Hubbard
Faculty
1 shared papers, latest 2018
Rabin Persad
Pediatrics Dept
1 shared papers, latest 2015
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.